Tuesday, November 10, 2026
The top medical stories of the day, as they ran.
Morning edition
15 stories
- 1FDA requires GLP-1 drugs to warn of rare vision-loss riskDrugs and FDA · 11 outlets
- 2Lilly’s oral GLP-1 pill reduced sleep apnea in phase 3 trialsDrugs and FDA · 6 outlets
- 3FDA approves Bayer’s Sunharbo to reduce stroke risk in certain adultsDrugs and FDA · 4 outlets
- 4Police investigate after 25 Santa Barbara half-marathon runners seek carePublic health · 2 outlets
- 5Nebraska cancer patient says he was told he lost Medicaid coverageMedicare and Medicaid · 2 outlets
- 6Trump administration announces $10B in rural health awardsHealth policy · 2 outlets
- 7Survodutide met cardiovascular safety goal in obesity trialDrugs and FDA · 2 outlets
- 8MAR001 lowered triglycerides in a phase 2b trialResearch · 3 outlets
- 9Abiomed advises removal of certain automated Impella controllersMedical devices · 1 outlet
- 10Level 2, Yellow Fever in Burkina Faso, Côte d’Ivoire, and GhanaOutbreaks · 1 outlet
- 11AI echo drafts met accuracy standard and reduced cardiologists’ reading timeResearch · 2 outlets
- 12U.S. imposes new rules on ordering synthetic DNA to deter bioterrorismHealth policy · 2 outlets
- 13FDA approves pirtobrutinib for relapsed or refractory mantle cell lymphomaDrugs and FDA · 1 outlet
- 14FDA grants accelerated approval to pirtobrutinib for CLL and SLLDrugs and FDA · 1 outlet
- 15Study finds smartwatch ECG results vary in detecting reduced heart functionDiagnostics · 2 outlets
Evening edition
12 stories
- 1FDA requires GLP-1 makers to warn of rare vision-loss riskDrugs and FDA · 10 outlets
- 2FDA approves Bayer’s Sunharbo to reduce recurrent stroke riskDrugs and FDA · 7 outlets
- 3Orforglipron improved sleep apnea in two phase 3 trialsResearch · 6 outlets
- 4PepGen reports early Phase 2 results for myotonic dystrophy drugDrugs and FDA · 3 outlets
- 5Trump administration announces second $10 billion rural health award roundHealth policy · 3 outlets
- 6Wisconsin and New York report measles deaths involving infantsInfectious disease · 1 outlet
- 7Oura to acquire Counsel Health for $625 millionIndustry · 3 outlets
- 8Vir’s hepatitis D drug combination succeeds in first Phase 3 studyDrugs and FDA · 2 outlets
- 9Democrats ask drugmakers to disclose Trump pricing agreementsHealth policy · 2 outlets
- 10Labcorp completes $375 million acquisition of Millennium HealthIndustry · 2 outlets
- 11ADA publications chief resigns amid boycott of the organizationResearch · 2 outlets
- 12Stopping GLP-1 treatment linked to higher cardiovascular risk in diabetesResearch · 2 outlets